Skip to main content
OpenTrials
Completed

NCT Number: NCT06457022

Outcome Measures of Modified Constraint Induced Movement Therapy Versus Dual Task Training on Upper Extremity and Cognitive Functions in Patients With Hemiparesis

All stroke patients were assessed via isokinetic dynamometer, Montreal cognitive assessment scale (MOCA) and Fugl Myer Upper extremity (FMUE) before and after the treatment program.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Hemiparesis Nervous System Diseases Neurologic Manifestations Paresis Pathological Conditions, Signs and Symptoms Signs and Symptoms

Age range

55 year–65 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Al Ryada University for Science and Technology

Sadat, Menoufia, Egypt

About this study

The patients were classified randomly into three equal groups, Study group A (GA) receiving modified constraint induced movement therapy in addition to conventional physical therapy program, Study group B (GB) receiving dual task training in addition to conventional physical therapy program and control group C (GC) receiving only conventional physiotherapy program.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients with age range between 55 and 65 years old.
  • The patients were from both genders (males &females).
  • Patients were of duration of illness between 6 and 12 months.
  • The patients were scoring 1 &1+ on modified Ashworth scale (mild spasticity).
  • The patients were of good ability to see and hear.
  • Consent form was obtained from all participants to approve the study and follow the commands.
  • All patients were scoring more than 26 on MMSE. All patients were medically stable.

Exclusion criteria

  • patients with moderate and sever spasticity.
  • patients with cognitive disorder due to other cause rather than spasticity.
  • patients with unstable medical conditions.
  • patients with previous or recurrent stroke.
  • patients with respiratory problems.
  • patients with shoulder dislocation or subluxation or frozen shoulder.
  • patients with uncontrolled hypertension, diabetes mellitus, unstable angina or heart failure.

Treatment and study plan

Modified Constraint Induced Movement Therapy

Other

patient wears a restraint instrument in his unaffected hand, then applying massed practice to his affected upper extremity. The patient wears padded glove in his unaffected upper extremity for restraining the patient from using his unaffected upper extremity for about 3 hours per day including the treatment session and the home program. So, by this way the patient is reinforced to use his affected upper extremity during this period of time to achieve his activities of daily living. Finally, the total time, the patient spends it during the day wearing the glove should be recorded each day.

Dual task training in the form of cognitive - motor task

Other

Verbal fluency: Ask the hemiparetic patient to title many words of specific type as fruits, vegetable or animals. Mental tracking: as the hemiparetic patient to subtract serial 3 between number 90 and 100.

Conventional Physiotherapy Rehabilitation Program

Other

Ultrasound on shoulder. Graduated active exercises for shoulder. Prolonged stretching for spastic muscles

Primary outcomes

  1. Biodex isokinetic dynamometer

    Time frame: 4 weeks

    Used to assess muscle strength and function

  2. Montreal cognitive assessment

    Time frame: 4 weeks

    a quick test that is used to examine mild cognitive impairment and early dementia.

  3. Fugl Myer upper extremity

    Time frame: 4 weeks

    a scale used to measure the functional impairment of stroke

Sponsors and collaborators

Lead sponsor

Ahmed Alshimy

Other

Registry information

Important dates

Study start
2024
Primary completion
2024
Study completion
2024
First posted
Jun 13, 2024
Registry last updated
Jul 19, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.